TDO2 and glioblastoma: Under these conditions, it was found that among the tryptophan degrading enzymes (IDO1, IDO2, and TDO2), the IDO1 expression was significantly higher in all different types of tumors compared to the brain cortex, except in IDHm GBM, although the exception could be due to the sample size (Figure 1A).